AGT and achalasia-alacrima syndrome: Furthermore, intervention with the glycolysis inhibitor PFK15 in an AngII model demonstrated that interference with glycolytic changes inhibited aneurysm formation, suggesting a clear parallel between metabolic changes in both human AAAs and the AngII model [106].